nodes	percent_of_prediction	percent_of_DWPC	metapath
Toremifene—CYP1A2—type 2 diabetes mellitus	0.226	0.602	CbGaD
Toremifene—CYP3A4—type 2 diabetes mellitus	0.15	0.398	CbGaD
Toremifene—ABCB1—Linagliptin—type 2 diabetes mellitus	0.0417	0.104	CbGbCtD
Toremifene—ABCB1—Sitagliptin—type 2 diabetes mellitus	0.0372	0.0927	CbGbCtD
Toremifene—CYP1A2—Rosiglitazone—type 2 diabetes mellitus	0.0284	0.0708	CbGbCtD
Toremifene—ABCB1—Chlorpropamide—type 2 diabetes mellitus	0.0269	0.067	CbGbCtD
Toremifene—CYP3A4—Linagliptin—type 2 diabetes mellitus	0.025	0.0623	CbGbCtD
Toremifene—CYP1A2—Irbesartan—type 2 diabetes mellitus	0.0223	0.0557	CbGbCtD
Toremifene—CYP3A4—Sitagliptin—type 2 diabetes mellitus	0.0223	0.0556	CbGbCtD
Toremifene—CYP1A2—Bromocriptine—type 2 diabetes mellitus	0.0211	0.0527	CbGbCtD
Toremifene—CYP3A4—Glipizide—type 2 diabetes mellitus	0.0204	0.0508	CbGbCtD
Toremifene—ABCB1—Bromocriptine—type 2 diabetes mellitus	0.0185	0.0461	CbGbCtD
Toremifene—CYP3A4—Repaglinide—type 2 diabetes mellitus	0.0178	0.0444	CbGbCtD
Toremifene—CYP3A4—Pioglitazone—type 2 diabetes mellitus	0.0161	0.0402	CbGbCtD
Toremifene—CYP1A2—Losartan—type 2 diabetes mellitus	0.0144	0.0359	CbGbCtD
Toremifene—ABCB1—Glyburide—type 2 diabetes mellitus	0.0138	0.0343	CbGbCtD
Toremifene—ABCB1—Losartan—type 2 diabetes mellitus	0.0126	0.0314	CbGbCtD
Toremifene—CYP3A4—Nateglinide—type 2 diabetes mellitus	0.0122	0.0304	CbGbCtD
Toremifene—CYP3A4—Orlistat—type 2 diabetes mellitus	0.0117	0.0292	CbGbCtD
Toremifene—CYP3A4—Irbesartan—type 2 diabetes mellitus	0.0117	0.0292	CbGbCtD
Toremifene—CYP3A4—Bromocriptine—type 2 diabetes mellitus	0.0111	0.0276	CbGbCtD
Toremifene—CYP3A4—Glyburide—type 2 diabetes mellitus	0.00825	0.0206	CbGbCtD
Toremifene—CYP3A4—Losartan—type 2 diabetes mellitus	0.00754	0.0188	CbGbCtD
Toremifene—Clomifene—CYP11A1—type 2 diabetes mellitus	0.000504	0.147	CrCbGaD
Toremifene—Loperamide—CALM1—type 2 diabetes mellitus	0.000378	0.11	CrCbGaD
Toremifene—Bedaquiline—CYP3A4—type 2 diabetes mellitus	0.000347	0.101	CrCbGaD
Toremifene—Phenoxybenzamine—CALM1—type 2 diabetes mellitus	0.000333	0.0968	CrCbGaD
Toremifene—Dizziness—Rosiglitazone—type 2 diabetes mellitus	0.000198	0.00128	CcSEcCtD
Toremifene—Nervous system disorder—Glyburide—type 2 diabetes mellitus	0.000197	0.00128	CcSEcCtD
Toremifene—Angina pectoris—Ramipril—type 2 diabetes mellitus	0.000197	0.00128	CcSEcCtD
Toremifene—Thrombocytopenia—Glyburide—type 2 diabetes mellitus	0.000197	0.00128	CcSEcCtD
Toremifene—Back pain—Valsartan—type 2 diabetes mellitus	0.000197	0.00128	CcSEcCtD
Toremifene—Dyspnoea—Bromocriptine—type 2 diabetes mellitus	0.000196	0.00127	CcSEcCtD
Toremifene—Hyperhidrosis—Glyburide—type 2 diabetes mellitus	0.000195	0.00126	CcSEcCtD
Toremifene—Back pain—Orlistat—type 2 diabetes mellitus	0.000194	0.00126	CcSEcCtD
Toremifene—Clomifene—CYP2E1—type 2 diabetes mellitus	0.000194	0.0565	CrCbGaD
Toremifene—Visual impairment—Irbesartan—type 2 diabetes mellitus	0.000194	0.00125	CcSEcCtD
Toremifene—Angiopathy—Metformin—type 2 diabetes mellitus	0.000193	0.00125	CcSEcCtD
Toremifene—Anorexia—Glyburide—type 2 diabetes mellitus	0.000192	0.00124	CcSEcCtD
Toremifene—Mediastinal disorder—Metformin—type 2 diabetes mellitus	0.000192	0.00124	CcSEcCtD
Toremifene—Vision blurred—Valsartan—type 2 diabetes mellitus	0.000192	0.00124	CcSEcCtD
Toremifene—Decreased appetite—Bromocriptine—type 2 diabetes mellitus	0.000191	0.00124	CcSEcCtD
Toremifene—Chills—Metformin—type 2 diabetes mellitus	0.000191	0.00124	CcSEcCtD
Toremifene—Gastrointestinal disorder—Bromocriptine—type 2 diabetes mellitus	0.00019	0.00123	CcSEcCtD
Toremifene—Fatigue—Bromocriptine—type 2 diabetes mellitus	0.00019	0.00123	CcSEcCtD
Toremifene—Vision blurred—Orlistat—type 2 diabetes mellitus	0.000189	0.00123	CcSEcCtD
Toremifene—Chest pain—Gliclazide—type 2 diabetes mellitus	0.000189	0.00122	CcSEcCtD
Toremifene—Rash—Rosiglitazone—type 2 diabetes mellitus	0.000188	0.00122	CcSEcCtD
Toremifene—Constipation—Bromocriptine—type 2 diabetes mellitus	0.000188	0.00122	CcSEcCtD
Toremifene—Dermatitis—Rosiglitazone—type 2 diabetes mellitus	0.000188	0.00122	CcSEcCtD
Toremifene—Nausea—Repaglinide—type 2 diabetes mellitus	0.000188	0.00122	CcSEcCtD
Toremifene—Asthenia—Glipizide—type 2 diabetes mellitus	0.000188	0.00122	CcSEcCtD
Toremifene—Unspecified disorder of skin and subcutaneous tissue—Gliclazide—type 2 diabetes mellitus	0.000187	0.00121	CcSEcCtD
Toremifene—Headache—Rosiglitazone—type 2 diabetes mellitus	0.000187	0.00121	CcSEcCtD
Toremifene—Malnutrition—Metformin—type 2 diabetes mellitus	0.000185	0.0012	CcSEcCtD
Toremifene—Pruritus—Glipizide—type 2 diabetes mellitus	0.000185	0.0012	CcSEcCtD
Toremifene—Clomifene—CYP1A2—type 2 diabetes mellitus	0.000185	0.0538	CrCbGaD
Toremifene—Weight increased—Ramipril—type 2 diabetes mellitus	0.000184	0.00119	CcSEcCtD
Toremifene—Vertigo—Valsartan—type 2 diabetes mellitus	0.000183	0.00118	CcSEcCtD
Toremifene—Angiopathy—Irbesartan—type 2 diabetes mellitus	0.000182	0.00118	CcSEcCtD
Toremifene—Mediastinal disorder—Irbesartan—type 2 diabetes mellitus	0.000181	0.00117	CcSEcCtD
Toremifene—Vertigo—Orlistat—type 2 diabetes mellitus	0.000181	0.00117	CcSEcCtD
Toremifene—Chills—Irbesartan—type 2 diabetes mellitus	0.00018	0.00117	CcSEcCtD
Toremifene—Asthenia—Pioglitazone—type 2 diabetes mellitus	0.00018	0.00116	CcSEcCtD
Toremifene—Dyspnoea—Glyburide—type 2 diabetes mellitus	0.000179	0.00116	CcSEcCtD
Toremifene—Arrhythmia—Irbesartan—type 2 diabetes mellitus	0.000179	0.00116	CcSEcCtD
Toremifene—Acute coronary syndrome—Ramipril—type 2 diabetes mellitus	0.000178	0.00115	CcSEcCtD
Toremifene—Nausea—Rosiglitazone—type 2 diabetes mellitus	0.000177	0.00115	CcSEcCtD
Toremifene—Nervous system disorder—Gliclazide—type 2 diabetes mellitus	0.000177	0.00115	CcSEcCtD
Toremifene—Myocardial infarction—Ramipril—type 2 diabetes mellitus	0.000177	0.00115	CcSEcCtD
Toremifene—Neuropathy peripheral—Ramipril—type 2 diabetes mellitus	0.000177	0.00115	CcSEcCtD
Toremifene—Thrombocytopenia—Gliclazide—type 2 diabetes mellitus	0.000177	0.00115	CcSEcCtD
Toremifene—Jaundice—Ramipril—type 2 diabetes mellitus	0.000176	0.00114	CcSEcCtD
Toremifene—Skin disorder—Gliclazide—type 2 diabetes mellitus	0.000176	0.00114	CcSEcCtD
Toremifene—Asthenia—Glimepiride—type 2 diabetes mellitus	0.000175	0.00113	CcSEcCtD
Toremifene—Decreased appetite—Glyburide—type 2 diabetes mellitus	0.000175	0.00113	CcSEcCtD
Toremifene—Malnutrition—Irbesartan—type 2 diabetes mellitus	0.000175	0.00113	CcSEcCtD
Toremifene—Hyperhidrosis—Gliclazide—type 2 diabetes mellitus	0.000175	0.00113	CcSEcCtD
Toremifene—Vision blurred—Metformin—type 2 diabetes mellitus	0.000175	0.00113	CcSEcCtD
Toremifene—Asthenia—Sitagliptin—type 2 diabetes mellitus	0.000175	0.00113	CcSEcCtD
Toremifene—Gastrointestinal disorder—Glyburide—type 2 diabetes mellitus	0.000174	0.00113	CcSEcCtD
Toremifene—Ospemifene—CYP3A4—type 2 diabetes mellitus	0.000174	0.0505	CrCbGaD
Toremifene—Tremor—Metformin—type 2 diabetes mellitus	0.000174	0.00112	CcSEcCtD
Toremifene—Chest pain—Valsartan—type 2 diabetes mellitus	0.000173	0.00112	CcSEcCtD
Toremifene—Sweating—Ramipril—type 2 diabetes mellitus	0.000173	0.00112	CcSEcCtD
Toremifene—Dizziness—Glipizide—type 2 diabetes mellitus	0.000173	0.00112	CcSEcCtD
Toremifene—Pruritus—Glimepiride—type 2 diabetes mellitus	0.000173	0.00112	CcSEcCtD
Toremifene—Unspecified disorder of skin and subcutaneous tissue—Valsartan—type 2 diabetes mellitus	0.000172	0.00111	CcSEcCtD
Toremifene—Angiopathy—Losartan—type 2 diabetes mellitus	0.000172	0.00111	CcSEcCtD
Toremifene—Chest pain—Orlistat—type 2 diabetes mellitus	0.000171	0.00111	CcSEcCtD
Toremifene—Hepatobiliary disease—Ramipril—type 2 diabetes mellitus	0.000171	0.00111	CcSEcCtD
Toremifene—Unspecified disorder of skin and subcutaneous tissue—Orlistat—type 2 diabetes mellitus	0.00017	0.0011	CcSEcCtD
Toremifene—Arrhythmia—Losartan—type 2 diabetes mellitus	0.000169	0.00109	CcSEcCtD
Toremifene—Alopecia—Losartan—type 2 diabetes mellitus	0.000167	0.00108	CcSEcCtD
Toremifene—Vomiting—Glipizide—type 2 diabetes mellitus	0.000166	0.00108	CcSEcCtD
Toremifene—Oedema—Valsartan—type 2 diabetes mellitus	0.000166	0.00108	CcSEcCtD
Toremifene—Dizziness—Pioglitazone—type 2 diabetes mellitus	0.000166	0.00107	CcSEcCtD
Toremifene—Rash—Glipizide—type 2 diabetes mellitus	0.000165	0.00107	CcSEcCtD
Toremifene—Vision blurred—Irbesartan—type 2 diabetes mellitus	0.000165	0.00107	CcSEcCtD
Toremifene—Dermatitis—Glipizide—type 2 diabetes mellitus	0.000165	0.00107	CcSEcCtD
Toremifene—Oedema—Orlistat—type 2 diabetes mellitus	0.000164	0.00106	CcSEcCtD
Toremifene—Headache—Glipizide—type 2 diabetes mellitus	0.000164	0.00106	CcSEcCtD
Toremifene—Tremor—Irbesartan—type 2 diabetes mellitus	0.000164	0.00106	CcSEcCtD
Toremifene—Insomnia—Gliclazide—type 2 diabetes mellitus	0.000163	0.00106	CcSEcCtD
Toremifene—Nervous system disorder—Valsartan—type 2 diabetes mellitus	0.000163	0.00106	CcSEcCtD
Toremifene—Thrombocytopenia—Valsartan—type 2 diabetes mellitus	0.000163	0.00105	CcSEcCtD
Toremifene—Dizziness—Glimepiride—type 2 diabetes mellitus	0.000161	0.00105	CcSEcCtD
Toremifene—Skin disorder—Valsartan—type 2 diabetes mellitus	0.000161	0.00105	CcSEcCtD
Toremifene—Dyspnoea—Gliclazide—type 2 diabetes mellitus	0.000161	0.00104	CcSEcCtD
Toremifene—Nervous system disorder—Orlistat—type 2 diabetes mellitus	0.000161	0.00104	CcSEcCtD
Toremifene—Dizziness—Sitagliptin—type 2 diabetes mellitus	0.000161	0.00104	CcSEcCtD
Toremifene—Skin disorder—Orlistat—type 2 diabetes mellitus	0.000159	0.00103	CcSEcCtD
Toremifene—Back pain—Losartan—type 2 diabetes mellitus	0.000159	0.00103	CcSEcCtD
Toremifene—Hyperhidrosis—Orlistat—type 2 diabetes mellitus	0.000159	0.00103	CcSEcCtD
Toremifene—Anorexia—Valsartan—type 2 diabetes mellitus	0.000158	0.00103	CcSEcCtD
Toremifene—Asthenia—Bromocriptine—type 2 diabetes mellitus	0.000158	0.00102	CcSEcCtD
Toremifene—Chest pain—Metformin—type 2 diabetes mellitus	0.000158	0.00102	CcSEcCtD
Toremifene—Benzphetamine—ADRA2A—type 2 diabetes mellitus	0.000158	0.0459	CrCbGaD
Toremifene—Vertigo—Irbesartan—type 2 diabetes mellitus	0.000157	0.00102	CcSEcCtD
Toremifene—Headache—Pioglitazone—type 2 diabetes mellitus	0.000157	0.00102	CcSEcCtD
Toremifene—Unspecified disorder of skin and subcutaneous tissue—Metformin—type 2 diabetes mellitus	0.000157	0.00102	CcSEcCtD
Toremifene—Leukopenia—Irbesartan—type 2 diabetes mellitus	0.000157	0.00101	CcSEcCtD
Toremifene—Visual impairment—Ramipril—type 2 diabetes mellitus	0.000156	0.00101	CcSEcCtD
Toremifene—Gastrointestinal disorder—Gliclazide—type 2 diabetes mellitus	0.000156	0.00101	CcSEcCtD
Toremifene—Fatigue—Gliclazide—type 2 diabetes mellitus	0.000156	0.00101	CcSEcCtD
Toremifene—Nausea—Glipizide—type 2 diabetes mellitus	0.000155	0.00101	CcSEcCtD
Toremifene—Vomiting—Glimepiride—type 2 diabetes mellitus	0.000155	0.00101	CcSEcCtD
Toremifene—Vision blurred—Losartan—type 2 diabetes mellitus	0.000155	0.001	CcSEcCtD
Toremifene—Vomiting—Sitagliptin—type 2 diabetes mellitus	0.000155	0.001	CcSEcCtD
Toremifene—Pain—Gliclazide—type 2 diabetes mellitus	0.000155	0.001	CcSEcCtD
Toremifene—Constipation—Gliclazide—type 2 diabetes mellitus	0.000155	0.001	CcSEcCtD
Toremifene—Tremor—Losartan—type 2 diabetes mellitus	0.000154	0.000999	CcSEcCtD
Toremifene—Rash—Glimepiride—type 2 diabetes mellitus	0.000154	0.000997	CcSEcCtD
Toremifene—Dermatitis—Glimepiride—type 2 diabetes mellitus	0.000154	0.000996	CcSEcCtD
Toremifene—Rash—Sitagliptin—type 2 diabetes mellitus	0.000153	0.000994	CcSEcCtD
Toremifene—Dermatitis—Sitagliptin—type 2 diabetes mellitus	0.000153	0.000993	CcSEcCtD
Toremifene—Headache—Glimepiride—type 2 diabetes mellitus	0.000153	0.000991	CcSEcCtD
Toremifene—Headache—Sitagliptin—type 2 diabetes mellitus	0.000152	0.000988	CcSEcCtD
Toremifene—Oedema—Metformin—type 2 diabetes mellitus	0.000151	0.00098	CcSEcCtD
Toremifene—Phenoxybenzamine—ADRA2A—type 2 diabetes mellitus	0.000151	0.0438	CrCbGaD
Toremifene—Insomnia—Valsartan—type 2 diabetes mellitus	0.00015	0.000973	CcSEcCtD
Toremifene—Chest pain—Irbesartan—type 2 diabetes mellitus	0.000149	0.000965	CcSEcCtD
Toremifene—Insomnia—Orlistat—type 2 diabetes mellitus	0.000148	0.000962	CcSEcCtD
Toremifene—Nervous system disorder—Metformin—type 2 diabetes mellitus	0.000148	0.000961	CcSEcCtD
Toremifene—Thrombocytopenia—Metformin—type 2 diabetes mellitus	0.000148	0.000959	CcSEcCtD
Toremifene—Dyspnoea—Valsartan—type 2 diabetes mellitus	0.000148	0.000959	CcSEcCtD
Toremifene—Vertigo—Losartan—type 2 diabetes mellitus	0.000148	0.000958	CcSEcCtD
Toremifene—Unspecified disorder of skin and subcutaneous tissue—Irbesartan—type 2 diabetes mellitus	0.000148	0.000958	CcSEcCtD
Toremifene—Leukopenia—Losartan—type 2 diabetes mellitus	0.000147	0.000954	CcSEcCtD
Toremifene—Skin disorder—Metformin—type 2 diabetes mellitus	0.000147	0.000952	CcSEcCtD
Toremifene—Hyperhidrosis—Metformin—type 2 diabetes mellitus	0.000146	0.000947	CcSEcCtD
Toremifene—Mediastinal disorder—Ramipril—type 2 diabetes mellitus	0.000146	0.000947	CcSEcCtD
Toremifene—Dizziness—Bromocriptine—type 2 diabetes mellitus	0.000146	0.000943	CcSEcCtD
Toremifene—Nausea—Glimepiride—type 2 diabetes mellitus	0.000145	0.000939	CcSEcCtD
Toremifene—Arrhythmia—Ramipril—type 2 diabetes mellitus	0.000145	0.000938	CcSEcCtD
Toremifene—Nausea—Sitagliptin—type 2 diabetes mellitus	0.000145	0.000936	CcSEcCtD
Toremifene—Asthenia—Glyburide—type 2 diabetes mellitus	0.000144	0.000936	CcSEcCtD
Toremifene—Decreased appetite—Valsartan—type 2 diabetes mellitus	0.000144	0.000935	CcSEcCtD
Toremifene—Anorexia—Metformin—type 2 diabetes mellitus	0.000144	0.000934	CcSEcCtD
Toremifene—Gastrointestinal disorder—Valsartan—type 2 diabetes mellitus	0.000143	0.000929	CcSEcCtD
Toremifene—Alopecia—Ramipril—type 2 diabetes mellitus	0.000143	0.000928	CcSEcCtD
Toremifene—Fatigue—Valsartan—type 2 diabetes mellitus	0.000143	0.000928	CcSEcCtD
Toremifene—Oedema—Irbesartan—type 2 diabetes mellitus	0.000143	0.000925	CcSEcCtD
Toremifene—Decreased appetite—Orlistat—type 2 diabetes mellitus	0.000143	0.000924	CcSEcCtD
Toremifene—Pruritus—Glyburide—type 2 diabetes mellitus	0.000142	0.000923	CcSEcCtD
Toremifene—Mental disorder—Ramipril—type 2 diabetes mellitus	0.000142	0.00092	CcSEcCtD
Toremifene—Constipation—Valsartan—type 2 diabetes mellitus	0.000142	0.00092	CcSEcCtD
Toremifene—Gastrointestinal disorder—Orlistat—type 2 diabetes mellitus	0.000142	0.000918	CcSEcCtD
Toremifene—Fatigue—Orlistat—type 2 diabetes mellitus	0.000141	0.000917	CcSEcCtD
Toremifene—Malnutrition—Ramipril—type 2 diabetes mellitus	0.000141	0.000914	CcSEcCtD
Toremifene—Pain—Orlistat—type 2 diabetes mellitus	0.00014	0.000909	CcSEcCtD
Toremifene—Chest pain—Losartan—type 2 diabetes mellitus	0.00014	0.000908	CcSEcCtD
Toremifene—Vomiting—Bromocriptine—type 2 diabetes mellitus	0.00014	0.000907	CcSEcCtD
Toremifene—Nervous system disorder—Irbesartan—type 2 diabetes mellitus	0.00014	0.000907	CcSEcCtD
Toremifene—Thrombocytopenia—Irbesartan—type 2 diabetes mellitus	0.00014	0.000905	CcSEcCtD
Toremifene—Rash—Bromocriptine—type 2 diabetes mellitus	0.000139	0.0009	CcSEcCtD
Toremifene—Dermatitis—Bromocriptine—type 2 diabetes mellitus	0.000139	0.000899	CcSEcCtD
Toremifene—Skin disorder—Irbesartan—type 2 diabetes mellitus	0.000139	0.000898	CcSEcCtD
Toremifene—Hyperhidrosis—Irbesartan—type 2 diabetes mellitus	0.000138	0.000894	CcSEcCtD
Toremifene—Headache—Bromocriptine—type 2 diabetes mellitus	0.000138	0.000894	CcSEcCtD
Toremifene—Anorexia—Irbesartan—type 2 diabetes mellitus	0.000136	0.000881	CcSEcCtD
Toremifene—Dyspnoea—Metformin—type 2 diabetes mellitus	0.000135	0.000874	CcSEcCtD
Toremifene—Oedema—Losartan—type 2 diabetes mellitus	0.000134	0.00087	CcSEcCtD
Toremifene—Tremor—Ramipril—type 2 diabetes mellitus	0.000132	0.000857	CcSEcCtD
Toremifene—Nervous system disorder—Losartan—type 2 diabetes mellitus	0.000132	0.000853	CcSEcCtD
Toremifene—Thrombocytopenia—Losartan—type 2 diabetes mellitus	0.000131	0.000852	CcSEcCtD
Toremifene—Decreased appetite—Metformin—type 2 diabetes mellitus	0.000131	0.000852	CcSEcCtD
Toremifene—Nausea—Bromocriptine—type 2 diabetes mellitus	0.000131	0.000847	CcSEcCtD
Toremifene—Gastrointestinal disorder—Metformin—type 2 diabetes mellitus	0.000131	0.000846	CcSEcCtD
Toremifene—Fatigue—Metformin—type 2 diabetes mellitus	0.00013	0.000845	CcSEcCtD
Toremifene—Hyperhidrosis—Losartan—type 2 diabetes mellitus	0.00013	0.000841	CcSEcCtD
Toremifene—Asthenia—Gliclazide—type 2 diabetes mellitus	0.00013	0.00084	CcSEcCtD
Toremifene—Constipation—Metformin—type 2 diabetes mellitus	0.000129	0.000838	CcSEcCtD
Toremifene—Anorexia—Losartan—type 2 diabetes mellitus	0.000128	0.000829	CcSEcCtD
Toremifene—Vomiting—Glyburide—type 2 diabetes mellitus	0.000128	0.000829	CcSEcCtD
Toremifene—Tamoxifen—ABCC2—type 2 diabetes mellitus	0.000128	0.0372	CrCbGaD
Toremifene—Pruritus—Gliclazide—type 2 diabetes mellitus	0.000128	0.000829	CcSEcCtD
Toremifene—Dyspnoea—Irbesartan—type 2 diabetes mellitus	0.000127	0.000824	CcSEcCtD
Toremifene—Rash—Glyburide—type 2 diabetes mellitus	0.000127	0.000822	CcSEcCtD
Toremifene—Dermatitis—Glyburide—type 2 diabetes mellitus	0.000127	0.000822	CcSEcCtD
Toremifene—Vertigo—Ramipril—type 2 diabetes mellitus	0.000127	0.000821	CcSEcCtD
Toremifene—Leukopenia—Ramipril—type 2 diabetes mellitus	0.000126	0.000818	CcSEcCtD
Toremifene—Headache—Glyburide—type 2 diabetes mellitus	0.000126	0.000817	CcSEcCtD
Toremifene—Decreased appetite—Irbesartan—type 2 diabetes mellitus	0.000124	0.000804	CcSEcCtD
Toremifene—Gastrointestinal disorder—Irbesartan—type 2 diabetes mellitus	0.000123	0.000798	CcSEcCtD
Toremifene—Fatigue—Irbesartan—type 2 diabetes mellitus	0.000123	0.000797	CcSEcCtD
Toremifene—Clomifene—CYP3A4—type 2 diabetes mellitus	0.000122	0.0356	CrCbGaD
Toremifene—Constipation—Irbesartan—type 2 diabetes mellitus	0.000122	0.000791	CcSEcCtD
Toremifene—Pain—Irbesartan—type 2 diabetes mellitus	0.000122	0.000791	CcSEcCtD
Toremifene—Insomnia—Losartan—type 2 diabetes mellitus	0.000121	0.000787	CcSEcCtD
Toremifene—Chest pain—Ramipril—type 2 diabetes mellitus	0.00012	0.000778	CcSEcCtD
Toremifene—Dyspnoea—Losartan—type 2 diabetes mellitus	0.00012	0.000776	CcSEcCtD
Toremifene—Nausea—Glyburide—type 2 diabetes mellitus	0.00012	0.000775	CcSEcCtD
Toremifene—Dizziness—Gliclazide—type 2 diabetes mellitus	0.00012	0.000774	CcSEcCtD
Toremifene—Unspecified disorder of skin and subcutaneous tissue—Ramipril—type 2 diabetes mellitus	0.000119	0.000773	CcSEcCtD
Toremifene—Asthenia—Valsartan—type 2 diabetes mellitus	0.000119	0.000772	CcSEcCtD
Toremifene—Asthenia—Orlistat—type 2 diabetes mellitus	0.000118	0.000763	CcSEcCtD
Toremifene—Pruritus—Valsartan—type 2 diabetes mellitus	0.000117	0.000761	CcSEcCtD
Toremifene—Decreased appetite—Losartan—type 2 diabetes mellitus	0.000117	0.000756	CcSEcCtD
Toremifene—Pruritus—Orlistat—type 2 diabetes mellitus	0.000116	0.000752	CcSEcCtD
Toremifene—Fatigue—Losartan—type 2 diabetes mellitus	0.000116	0.00075	CcSEcCtD
Toremifene—Oedema—Ramipril—type 2 diabetes mellitus	0.000115	0.000746	CcSEcCtD
Toremifene—Vomiting—Gliclazide—type 2 diabetes mellitus	0.000115	0.000745	CcSEcCtD
Toremifene—Pain—Losartan—type 2 diabetes mellitus	0.000115	0.000744	CcSEcCtD
Toremifene—Constipation—Losartan—type 2 diabetes mellitus	0.000115	0.000744	CcSEcCtD
Toremifene—Rash—Gliclazide—type 2 diabetes mellitus	0.000114	0.000738	CcSEcCtD
Toremifene—Dermatitis—Gliclazide—type 2 diabetes mellitus	0.000114	0.000738	CcSEcCtD
Toremifene—Headache—Gliclazide—type 2 diabetes mellitus	0.000113	0.000734	CcSEcCtD
Toremifene—Nervous system disorder—Ramipril—type 2 diabetes mellitus	0.000113	0.000732	CcSEcCtD
Toremifene—Thrombocytopenia—Ramipril—type 2 diabetes mellitus	0.000113	0.000731	CcSEcCtD
Toremifene—Skin disorder—Ramipril—type 2 diabetes mellitus	0.000112	0.000725	CcSEcCtD
Toremifene—Hyperhidrosis—Ramipril—type 2 diabetes mellitus	0.000111	0.000721	CcSEcCtD
Toremifene—Dizziness—Valsartan—type 2 diabetes mellitus	0.00011	0.000711	CcSEcCtD
Toremifene—Anorexia—Ramipril—type 2 diabetes mellitus	0.00011	0.000711	CcSEcCtD
Toremifene—Dizziness—Orlistat—type 2 diabetes mellitus	0.000109	0.000703	CcSEcCtD
Toremifene—Asthenia—Metformin—type 2 diabetes mellitus	0.000108	0.000703	CcSEcCtD
Toremifene—Nausea—Gliclazide—type 2 diabetes mellitus	0.000107	0.000696	CcSEcCtD
Toremifene—Pruritus—Metformin—type 2 diabetes mellitus	0.000107	0.000693	CcSEcCtD
Toremifene—Vomiting—Valsartan—type 2 diabetes mellitus	0.000106	0.000684	CcSEcCtD
Toremifene—Rash—Valsartan—type 2 diabetes mellitus	0.000105	0.000678	CcSEcCtD
Toremifene—Dermatitis—Valsartan—type 2 diabetes mellitus	0.000105	0.000678	CcSEcCtD
Toremifene—Vomiting—Orlistat—type 2 diabetes mellitus	0.000104	0.000676	CcSEcCtD
Toremifene—Insomnia—Ramipril—type 2 diabetes mellitus	0.000104	0.000675	CcSEcCtD
Toremifene—Headache—Valsartan—type 2 diabetes mellitus	0.000104	0.000674	CcSEcCtD
Toremifene—Rash—Orlistat—type 2 diabetes mellitus	0.000103	0.00067	CcSEcCtD
Toremifene—Dermatitis—Orlistat—type 2 diabetes mellitus	0.000103	0.00067	CcSEcCtD
Toremifene—Headache—Orlistat—type 2 diabetes mellitus	0.000103	0.000666	CcSEcCtD
Toremifene—Dyspnoea—Ramipril—type 2 diabetes mellitus	0.000103	0.000665	CcSEcCtD
Toremifene—Asthenia—Irbesartan—type 2 diabetes mellitus	0.000102	0.000663	CcSEcCtD
Toremifene—Pruritus—Irbesartan—type 2 diabetes mellitus	0.000101	0.000654	CcSEcCtD
Toremifene—Decreased appetite—Ramipril—type 2 diabetes mellitus	0.0001	0.000649	CcSEcCtD
Toremifene—Dizziness—Metformin—type 2 diabetes mellitus	0.0001	0.000648	CcSEcCtD
Toremifene—Gastrointestinal disorder—Ramipril—type 2 diabetes mellitus	9.94e-05	0.000644	CcSEcCtD
Toremifene—Fatigue—Ramipril—type 2 diabetes mellitus	9.93e-05	0.000643	CcSEcCtD
Toremifene—Nausea—Valsartan—type 2 diabetes mellitus	9.86e-05	0.000639	CcSEcCtD
Toremifene—Constipation—Ramipril—type 2 diabetes mellitus	9.85e-05	0.000638	CcSEcCtD
Toremifene—Nausea—Orlistat—type 2 diabetes mellitus	9.75e-05	0.000632	CcSEcCtD
Toremifene—Asthenia—Losartan—type 2 diabetes mellitus	9.64e-05	0.000624	CcSEcCtD
Toremifene—Vomiting—Metformin—type 2 diabetes mellitus	9.61e-05	0.000623	CcSEcCtD
Toremifene—Rash—Metformin—type 2 diabetes mellitus	9.53e-05	0.000618	CcSEcCtD
Toremifene—Dermatitis—Metformin—type 2 diabetes mellitus	9.53e-05	0.000617	CcSEcCtD
Toremifene—Pruritus—Losartan—type 2 diabetes mellitus	9.5e-05	0.000616	CcSEcCtD
Toremifene—Headache—Metformin—type 2 diabetes mellitus	9.47e-05	0.000614	CcSEcCtD
Toremifene—Dizziness—Irbesartan—type 2 diabetes mellitus	9.44e-05	0.000611	CcSEcCtD
Toremifene—Vomiting—Irbesartan—type 2 diabetes mellitus	9.07e-05	0.000588	CcSEcCtD
Toremifene—Rash—Irbesartan—type 2 diabetes mellitus	9e-05	0.000583	CcSEcCtD
Toremifene—Dermatitis—Irbesartan—type 2 diabetes mellitus	8.99e-05	0.000582	CcSEcCtD
Toremifene—Nausea—Metformin—type 2 diabetes mellitus	8.98e-05	0.000582	CcSEcCtD
Toremifene—Tamoxifen—CYP2E1—type 2 diabetes mellitus	8.98e-05	0.0261	CrCbGaD
Toremifene—Headache—Irbesartan—type 2 diabetes mellitus	8.94e-05	0.000579	CcSEcCtD
Toremifene—Dizziness—Losartan—type 2 diabetes mellitus	8.88e-05	0.000575	CcSEcCtD
Toremifene—Diphenhydramine—CYP1A2—type 2 diabetes mellitus	8.77e-05	0.0255	CrCbGaD
Toremifene—Orphenadrine—CYP2E1—type 2 diabetes mellitus	8.72e-05	0.0254	CrCbGaD
Toremifene—Tamoxifen—CYP1A2—type 2 diabetes mellitus	8.54e-05	0.0248	CrCbGaD
Toremifene—Vomiting—Losartan—type 2 diabetes mellitus	8.54e-05	0.000553	CcSEcCtD
Toremifene—Nausea—Irbesartan—type 2 diabetes mellitus	8.48e-05	0.000549	CcSEcCtD
Toremifene—Rash—Losartan—type 2 diabetes mellitus	8.47e-05	0.000549	CcSEcCtD
Toremifene—Dermatitis—Losartan—type 2 diabetes mellitus	8.46e-05	0.000548	CcSEcCtD
Toremifene—Headache—Losartan—type 2 diabetes mellitus	8.41e-05	0.000545	CcSEcCtD
Toremifene—Dextropropoxyphene—CYP3A4—type 2 diabetes mellitus	8.27e-05	0.024	CrCbGaD
Toremifene—Asthenia—Ramipril—type 2 diabetes mellitus	8.26e-05	0.000535	CcSEcCtD
Toremifene—Pruritus—Ramipril—type 2 diabetes mellitus	8.15e-05	0.000528	CcSEcCtD
Toremifene—Nausea—Losartan—type 2 diabetes mellitus	7.98e-05	0.000517	CcSEcCtD
Toremifene—Loperamide—CYP3A4—type 2 diabetes mellitus	7.88e-05	0.0229	CrCbGaD
Toremifene—Dizziness—Ramipril—type 2 diabetes mellitus	7.61e-05	0.000493	CcSEcCtD
Toremifene—Vomiting—Ramipril—type 2 diabetes mellitus	7.32e-05	0.000474	CcSEcCtD
Toremifene—Rash—Ramipril—type 2 diabetes mellitus	7.26e-05	0.00047	CcSEcCtD
Toremifene—Dermatitis—Ramipril—type 2 diabetes mellitus	7.25e-05	0.00047	CcSEcCtD
Toremifene—Benzphetamine—CYP3A4—type 2 diabetes mellitus	7.25e-05	0.0211	CrCbGaD
Toremifene—Headache—Ramipril—type 2 diabetes mellitus	7.21e-05	0.000467	CcSEcCtD
Toremifene—Phenoxybenzamine—CYP3A4—type 2 diabetes mellitus	6.93e-05	0.0202	CrCbGaD
Toremifene—Nausea—Ramipril—type 2 diabetes mellitus	6.84e-05	0.000443	CcSEcCtD
Toremifene—Tamoxifen—CYP3A4—type 2 diabetes mellitus	5.66e-05	0.0165	CrCbGaD
Toremifene—Orphenadrine—CYP3A4—type 2 diabetes mellitus	5.49e-05	0.016	CrCbGaD
Toremifene—CYP1A1—Metabolism of lipids and lipoproteins—PIK3R1—type 2 diabetes mellitus	9.53e-06	0.000146	CbGpPWpGaD
Toremifene—CYP3A4—Metabolism—SRD5A1—type 2 diabetes mellitus	9.49e-06	0.000145	CbGpPWpGaD
Toremifene—ESR1—Signaling Pathways—TGFBR2—type 2 diabetes mellitus	9.46e-06	0.000145	CbGpPWpGaD
Toremifene—CYP1A1—Metabolism—ADRA2A—type 2 diabetes mellitus	9.46e-06	0.000145	CbGpPWpGaD
Toremifene—CYP1A2—Metabolism of lipids and lipoproteins—GPX1—type 2 diabetes mellitus	9.44e-06	0.000144	CbGpPWpGaD
Toremifene—ESR1—Signaling Pathways—GNB3—type 2 diabetes mellitus	9.37e-06	0.000143	CbGpPWpGaD
Toremifene—ABCB1—Metabolism—SLC2A2—type 2 diabetes mellitus	9.27e-06	0.000142	CbGpPWpGaD
Toremifene—ESR1—Signaling Pathways—AVP—type 2 diabetes mellitus	9.25e-06	0.000141	CbGpPWpGaD
Toremifene—ESR1—Signaling Pathways—MMP3—type 2 diabetes mellitus	9.25e-06	0.000141	CbGpPWpGaD
Toremifene—CYP1A2—Metabolism—HK1—type 2 diabetes mellitus	9.21e-06	0.000141	CbGpPWpGaD
Toremifene—ESR1—Signaling Pathways—IGF2—type 2 diabetes mellitus	9.21e-06	0.000141	CbGpPWpGaD
Toremifene—CYP1A2—Metabolism of lipids and lipoproteins—CD36—type 2 diabetes mellitus	9.2e-06	0.000141	CbGpPWpGaD
Toremifene—ESR1—Signaling Pathways—CDKN2B—type 2 diabetes mellitus	9.17e-06	0.00014	CbGpPWpGaD
Toremifene—CYP1A1—Metabolism—CYP2E1—type 2 diabetes mellitus	9.09e-06	0.000139	CbGpPWpGaD
Toremifene—ABCB1—Metabolism—MTR—type 2 diabetes mellitus	9.08e-06	0.000139	CbGpPWpGaD
Toremifene—ABCB1—Metabolism—CPT1A—type 2 diabetes mellitus	9.08e-06	0.000139	CbGpPWpGaD
Toremifene—CYP3A4—Metabolism—HSD17B3—type 2 diabetes mellitus	9.06e-06	0.000138	CbGpPWpGaD
Toremifene—CYP3A4—Metabolism—STAR—type 2 diabetes mellitus	9.06e-06	0.000138	CbGpPWpGaD
Toremifene—CYP3A4—Metabolism—ACACA—type 2 diabetes mellitus	9.06e-06	0.000138	CbGpPWpGaD
Toremifene—CYP1A1—Metabolism—SLC2A1—type 2 diabetes mellitus	8.99e-06	0.000137	CbGpPWpGaD
Toremifene—CYP1A1—Metabolism—CYP1A2—type 2 diabetes mellitus	8.99e-06	0.000137	CbGpPWpGaD
Toremifene—ESR1—Signaling Pathways—APOB—type 2 diabetes mellitus	8.94e-06	0.000137	CbGpPWpGaD
Toremifene—ABCB1—Metabolism—NAMPT—type 2 diabetes mellitus	8.9e-06	0.000136	CbGpPWpGaD
Toremifene—ESR1—Signaling Pathways—IGF1R—type 2 diabetes mellitus	8.9e-06	0.000136	CbGpPWpGaD
Toremifene—CYP1A2—Metabolism—GCKR—type 2 diabetes mellitus	8.89e-06	0.000136	CbGpPWpGaD
Toremifene—CYP1A2—Metabolism—LPA—type 2 diabetes mellitus	8.89e-06	0.000136	CbGpPWpGaD
Toremifene—CYP1A2—Metabolism—KCNJ11—type 2 diabetes mellitus	8.89e-06	0.000136	CbGpPWpGaD
Toremifene—CYP1A2—Metabolism—HSD3B2—type 2 diabetes mellitus	8.89e-06	0.000136	CbGpPWpGaD
Toremifene—ABCB1—Metabolism—HBA1—type 2 diabetes mellitus	8.85e-06	0.000135	CbGpPWpGaD
Toremifene—ABCB1—Metabolism—GCK—type 2 diabetes mellitus	8.85e-06	0.000135	CbGpPWpGaD
Toremifene—ABCB1—Metabolism—LIPC—type 2 diabetes mellitus	8.85e-06	0.000135	CbGpPWpGaD
Toremifene—ESR1—Signaling Pathways—EDN1—type 2 diabetes mellitus	8.8e-06	0.000134	CbGpPWpGaD
Toremifene—ABCB1—Metabolism—CYP11A1—type 2 diabetes mellitus	8.79e-06	0.000134	CbGpPWpGaD
Toremifene—CYP1A1—Metabolism—CYP3A4—type 2 diabetes mellitus	8.76e-06	0.000134	CbGpPWpGaD
Toremifene—CYP1A1—Metabolism of lipids and lipoproteins—PTGS2—type 2 diabetes mellitus	8.72e-06	0.000133	CbGpPWpGaD
Toremifene—CYP3A4—Metabolism—CBS—type 2 diabetes mellitus	8.68e-06	0.000133	CbGpPWpGaD
Toremifene—CYP3A4—Metabolism—ABCC8—type 2 diabetes mellitus	8.68e-06	0.000133	CbGpPWpGaD
Toremifene—ABCB1—Metabolism—SLC9A1—type 2 diabetes mellitus	8.64e-06	0.000132	CbGpPWpGaD
Toremifene—ESR1—Gene Expression—SERPINE1—type 2 diabetes mellitus	8.63e-06	0.000132	CbGpPWpGaD
Toremifene—CYP1A1—Metabolism—GCG—type 2 diabetes mellitus	8.62e-06	0.000132	CbGpPWpGaD
Toremifene—CYP1A1—Metabolism—SLC2A4—type 2 diabetes mellitus	8.62e-06	0.000132	CbGpPWpGaD
Toremifene—CYP1A2—Metabolism of lipids and lipoproteins—PPARA—type 2 diabetes mellitus	8.55e-06	0.000131	CbGpPWpGaD
Toremifene—ABCB1—Metabolism—CETP—type 2 diabetes mellitus	8.54e-06	0.000131	CbGpPWpGaD
Toremifene—ESR1—Signaling Pathways—LPL—type 2 diabetes mellitus	8.53e-06	0.00013	CbGpPWpGaD
Toremifene—CYP1A2—Metabolism—ALDOB—type 2 diabetes mellitus	8.52e-06	0.00013	CbGpPWpGaD
Toremifene—ABCB1—Integrated Pancreatic Cancer Pathway—AKT1—type 2 diabetes mellitus	8.38e-06	0.000128	CbGpPWpGaD
Toremifene—CYP3A4—Metabolism—COX2—type 2 diabetes mellitus	8.36e-06	0.000128	CbGpPWpGaD
Toremifene—CYP3A4—Metabolism—SLC5A2—type 2 diabetes mellitus	8.36e-06	0.000128	CbGpPWpGaD
Toremifene—ESR1—Signaling Pathways—ADCY5—type 2 diabetes mellitus	8.35e-06	0.000128	CbGpPWpGaD
Toremifene—CYP1A2—Metabolism of lipids and lipoproteins—AGT—type 2 diabetes mellitus	8.28e-06	0.000127	CbGpPWpGaD
Toremifene—CYP3A4—Metabolism—NCOA6—type 2 diabetes mellitus	8.21e-06	0.000126	CbGpPWpGaD
Toremifene—CYP1A2—Metabolism of lipids and lipoproteins—APOE—type 2 diabetes mellitus	8.11e-06	0.000124	CbGpPWpGaD
Toremifene—CYP3A4—Metabolism—UCP3—type 2 diabetes mellitus	8.07e-06	0.000123	CbGpPWpGaD
Toremifene—CYP3A4—Metabolism—UCP2—type 2 diabetes mellitus	8.07e-06	0.000123	CbGpPWpGaD
Toremifene—CYP3A4—Metabolism—HSD11B1—type 2 diabetes mellitus	8.07e-06	0.000123	CbGpPWpGaD
Toremifene—CYP1A2—Metabolism of lipids and lipoproteins—APOA1—type 2 diabetes mellitus	8.02e-06	0.000123	CbGpPWpGaD
Toremifene—ESR1—Signaling Pathways—PPP2CA—type 2 diabetes mellitus	8.01e-06	0.000122	CbGpPWpGaD
Toremifene—ABCB1—Metabolism—PSMD6—type 2 diabetes mellitus	7.94e-06	0.000121	CbGpPWpGaD
Toremifene—ABCB1—Metabolism—SNAP25—type 2 diabetes mellitus	7.94e-06	0.000121	CbGpPWpGaD
Toremifene—ABCB1—Metabolism—SREBF1—type 2 diabetes mellitus	7.94e-06	0.000121	CbGpPWpGaD
Toremifene—CYP1A2—Metabolism—GLP1R—type 2 diabetes mellitus	7.93e-06	0.000121	CbGpPWpGaD
Toremifene—ESR1—Signaling Pathways—CCR5—type 2 diabetes mellitus	7.86e-06	0.00012	CbGpPWpGaD
Toremifene—ABCB1—Metabolism—CTGF—type 2 diabetes mellitus	7.79e-06	0.000119	CbGpPWpGaD
Toremifene—ABCB1—Metabolism—HMGCR—type 2 diabetes mellitus	7.72e-06	0.000118	CbGpPWpGaD
Toremifene—ESR1—Signaling Pathways—C3—type 2 diabetes mellitus	7.68e-06	0.000117	CbGpPWpGaD
Toremifene—CYP3A4—Metabolism—PCK1—type 2 diabetes mellitus	7.59e-06	0.000116	CbGpPWpGaD
Toremifene—ABCB1—Transmembrane transport of small molecules—ALB—type 2 diabetes mellitus	7.57e-06	0.000116	CbGpPWpGaD
Toremifene—ABCB1—Metabolism—ADRA2A—type 2 diabetes mellitus	7.56e-06	0.000116	CbGpPWpGaD
Toremifene—CYP1A1—Metabolism—GNB3—type 2 diabetes mellitus	7.43e-06	0.000114	CbGpPWpGaD
Toremifene—CYP1A1—Metabolism—PPARGC1A—type 2 diabetes mellitus	7.43e-06	0.000114	CbGpPWpGaD
Toremifene—CYP1A2—Metabolism—SLC2A2—type 2 diabetes mellitus	7.4e-06	0.000113	CbGpPWpGaD
Toremifene—CYP1A1—Metabolism—HMOX1—type 2 diabetes mellitus	7.39e-06	0.000113	CbGpPWpGaD
Toremifene—ESR1—Signaling Pathways—HIF1A—type 2 diabetes mellitus	7.33e-06	0.000112	CbGpPWpGaD
Toremifene—ESR1—Signaling Pathways—IRS2—type 2 diabetes mellitus	7.31e-06	0.000112	CbGpPWpGaD
Toremifene—ESR1—Signaling Pathways—AGT—type 2 diabetes mellitus	7.3e-06	0.000112	CbGpPWpGaD
Toremifene—CYP1A1—Metabolism—CAT—type 2 diabetes mellitus	7.29e-06	0.000112	CbGpPWpGaD
Toremifene—ABCB1—Metabolism—CYP2E1—type 2 diabetes mellitus	7.26e-06	0.000111	CbGpPWpGaD
Toremifene—CYP1A2—Metabolism—CPT1A—type 2 diabetes mellitus	7.25e-06	0.000111	CbGpPWpGaD
Toremifene—CYP1A2—Metabolism—MTR—type 2 diabetes mellitus	7.25e-06	0.000111	CbGpPWpGaD
Toremifene—ESR1—Signaling Pathways—CALM1—type 2 diabetes mellitus	7.18e-06	0.00011	CbGpPWpGaD
Toremifene—ABCB1—Metabolism—SLC2A1—type 2 diabetes mellitus	7.18e-06	0.00011	CbGpPWpGaD
Toremifene—ABCB1—Metabolism—CYP1A2—type 2 diabetes mellitus	7.18e-06	0.00011	CbGpPWpGaD
Toremifene—ESR1—Signaling Pathways—LEP—type 2 diabetes mellitus	7.15e-06	0.000109	CbGpPWpGaD
Toremifene—ESR1—Signaling Pathways—APOE—type 2 diabetes mellitus	7.15e-06	0.000109	CbGpPWpGaD
Toremifene—CYP1A2—Metabolism—NAMPT—type 2 diabetes mellitus	7.11e-06	0.000109	CbGpPWpGaD
Toremifene—CYP3A4—Metabolism—HK1—type 2 diabetes mellitus	7.11e-06	0.000109	CbGpPWpGaD
Toremifene—CYP1A1—Metabolism—APOB—type 2 diabetes mellitus	7.08e-06	0.000108	CbGpPWpGaD
Toremifene—ESR1—Signaling Pathways—APOA1—type 2 diabetes mellitus	7.07e-06	0.000108	CbGpPWpGaD
Toremifene—CYP1A2—Metabolism of lipids and lipoproteins—PPARG—type 2 diabetes mellitus	7.07e-06	0.000108	CbGpPWpGaD
Toremifene—CYP1A2—Metabolism—HBA1—type 2 diabetes mellitus	7.06e-06	0.000108	CbGpPWpGaD
Toremifene—CYP1A2—Metabolism—LIPC—type 2 diabetes mellitus	7.06e-06	0.000108	CbGpPWpGaD
Toremifene—CYP1A2—Metabolism—GCK—type 2 diabetes mellitus	7.06e-06	0.000108	CbGpPWpGaD
Toremifene—CYP1A2—Metabolism—CYP11A1—type 2 diabetes mellitus	7.02e-06	0.000107	CbGpPWpGaD
Toremifene—ABCB1—Metabolism—CYP3A4—type 2 diabetes mellitus	7e-06	0.000107	CbGpPWpGaD
Toremifene—CYP1A2—Metabolism—SLC9A1—type 2 diabetes mellitus	6.89e-06	0.000105	CbGpPWpGaD
Toremifene—CYP1A1—Metabolism—GSTM1—type 2 diabetes mellitus	6.89e-06	0.000105	CbGpPWpGaD
Toremifene—ABCB1—Metabolism—GCG—type 2 diabetes mellitus	6.88e-06	0.000105	CbGpPWpGaD
Toremifene—ABCB1—Metabolism—SLC2A4—type 2 diabetes mellitus	6.88e-06	0.000105	CbGpPWpGaD
Toremifene—CYP3A4—Metabolism—LPA—type 2 diabetes mellitus	6.86e-06	0.000105	CbGpPWpGaD
Toremifene—CYP3A4—Metabolism—KCNJ11—type 2 diabetes mellitus	6.86e-06	0.000105	CbGpPWpGaD
Toremifene—CYP3A4—Metabolism—HSD3B2—type 2 diabetes mellitus	6.86e-06	0.000105	CbGpPWpGaD
Toremifene—CYP3A4—Metabolism—GCKR—type 2 diabetes mellitus	6.86e-06	0.000105	CbGpPWpGaD
Toremifene—CYP1A2—Metabolism—CETP—type 2 diabetes mellitus	6.82e-06	0.000104	CbGpPWpGaD
Toremifene—CYP1A1—Metabolism—LPL—type 2 diabetes mellitus	6.76e-06	0.000103	CbGpPWpGaD
Toremifene—ESR1—Signaling Pathways—PRKCB—type 2 diabetes mellitus	6.75e-06	0.000103	CbGpPWpGaD
Toremifene—CYP1A1—Metabolism—ADCY5—type 2 diabetes mellitus	6.62e-06	0.000101	CbGpPWpGaD
Toremifene—CYP1A1—Metabolism—GPX1—type 2 diabetes mellitus	6.6e-06	0.000101	CbGpPWpGaD
Toremifene—CYP3A4—Metabolism—ALDOB—type 2 diabetes mellitus	6.58e-06	0.000101	CbGpPWpGaD
Toremifene—CYP1A1—Metabolism—CD36—type 2 diabetes mellitus	6.42e-06	9.82e-05	CbGpPWpGaD
Toremifene—ESR1—Signaling Pathways—IRS1—type 2 diabetes mellitus	6.38e-06	9.76e-05	CbGpPWpGaD
Toremifene—CYP1A2—Metabolism of lipids and lipoproteins—ALB—type 2 diabetes mellitus	6.35e-06	9.72e-05	CbGpPWpGaD
Toremifene—CYP1A1—Metabolism—PPP2CA—type 2 diabetes mellitus	6.34e-06	9.7e-05	CbGpPWpGaD
Toremifene—CYP1A2—Metabolism—PSMD6—type 2 diabetes mellitus	6.34e-06	9.69e-05	CbGpPWpGaD
Toremifene—CYP1A2—Metabolism—SNAP25—type 2 diabetes mellitus	6.34e-06	9.69e-05	CbGpPWpGaD
Toremifene—CYP1A2—Metabolism—SREBF1—type 2 diabetes mellitus	6.34e-06	9.69e-05	CbGpPWpGaD
Toremifene—CYP1A2—Metabolism—CTGF—type 2 diabetes mellitus	6.22e-06	9.51e-05	CbGpPWpGaD
Toremifene—CYP1A2—Metabolism—HMGCR—type 2 diabetes mellitus	6.16e-06	9.42e-05	CbGpPWpGaD
Toremifene—CYP3A4—Metabolism—GLP1R—type 2 diabetes mellitus	6.12e-06	9.35e-05	CbGpPWpGaD
Toremifene—ESR1—Signaling Pathways—INS—type 2 diabetes mellitus	6.11e-06	9.34e-05	CbGpPWpGaD
Toremifene—CYP1A1—Metabolism—MTHFR—type 2 diabetes mellitus	6.09e-06	9.31e-05	CbGpPWpGaD
Toremifene—CYP1A2—Metabolism of lipids and lipoproteins—PIK3R1—type 2 diabetes mellitus	6.08e-06	9.29e-05	CbGpPWpGaD
Toremifene—CYP1A2—Metabolism—ADRA2A—type 2 diabetes mellitus	6.03e-06	9.22e-05	CbGpPWpGaD
Toremifene—ESR1—Signaling Pathways—CCL2—type 2 diabetes mellitus	6.01e-06	9.19e-05	CbGpPWpGaD
Toremifene—CYP1A1—Metabolism—PPARA—type 2 diabetes mellitus	5.97e-06	9.13e-05	CbGpPWpGaD
Toremifene—ABCB1—Metabolism—GNB3—type 2 diabetes mellitus	5.93e-06	9.07e-05	CbGpPWpGaD
Toremifene—ABCB1—Metabolism—PPARGC1A—type 2 diabetes mellitus	5.93e-06	9.07e-05	CbGpPWpGaD
Toremifene—ESR1—Signaling Pathways—IGF1—type 2 diabetes mellitus	5.91e-06	9.04e-05	CbGpPWpGaD
Toremifene—ESR1—Signaling Pathways—AKT2—type 2 diabetes mellitus	5.91e-06	9.03e-05	CbGpPWpGaD
Toremifene—ABCB1—Metabolism—HMOX1—type 2 diabetes mellitus	5.9e-06	9.03e-05	CbGpPWpGaD
Toremifene—ABCB1—Metabolism—CAT—type 2 diabetes mellitus	5.83e-06	8.91e-05	CbGpPWpGaD
Toremifene—CYP1A2—Metabolism—CYP2E1—type 2 diabetes mellitus	5.79e-06	8.86e-05	CbGpPWpGaD
Toremifene—CYP1A1—Metabolism—AGT—type 2 diabetes mellitus	5.78e-06	8.84e-05	CbGpPWpGaD
Toremifene—CYP1A2—Metabolism—SLC2A1—type 2 diabetes mellitus	5.73e-06	8.76e-05	CbGpPWpGaD
Toremifene—CYP3A4—Metabolism—SLC2A2—type 2 diabetes mellitus	5.71e-06	8.73e-05	CbGpPWpGaD
Toremifene—CYP1A1—Metabolism—CALM1—type 2 diabetes mellitus	5.69e-06	8.7e-05	CbGpPWpGaD
Toremifene—CYP1A1—Metabolism—APOE—type 2 diabetes mellitus	5.67e-06	8.66e-05	CbGpPWpGaD
Toremifene—ABCB1—Metabolism—APOB—type 2 diabetes mellitus	5.66e-06	8.65e-05	CbGpPWpGaD
Toremifene—ESR1—Signaling Pathways—SERPINE1—type 2 diabetes mellitus	5.61e-06	8.58e-05	CbGpPWpGaD
Toremifene—CYP1A1—Metabolism—APOA1—type 2 diabetes mellitus	5.6e-06	8.57e-05	CbGpPWpGaD
Toremifene—CYP3A4—Metabolism—CPT1A—type 2 diabetes mellitus	5.59e-06	8.55e-05	CbGpPWpGaD
Toremifene—CYP3A4—Metabolism—MTR—type 2 diabetes mellitus	5.59e-06	8.55e-05	CbGpPWpGaD
Toremifene—CYP1A2—Metabolism—CYP3A4—type 2 diabetes mellitus	5.59e-06	8.54e-05	CbGpPWpGaD
Toremifene—CYP1A2—Metabolism of lipids and lipoproteins—PTGS2—type 2 diabetes mellitus	5.56e-06	8.5e-05	CbGpPWpGaD
Toremifene—ABCB1—Metabolism—GSTM1—type 2 diabetes mellitus	5.5e-06	8.41e-05	CbGpPWpGaD
Toremifene—CYP1A2—Metabolism—GCG—type 2 diabetes mellitus	5.49e-06	8.4e-05	CbGpPWpGaD
Toremifene—CYP1A2—Metabolism—SLC2A4—type 2 diabetes mellitus	5.49e-06	8.4e-05	CbGpPWpGaD
Toremifene—CYP3A4—Metabolism—NAMPT—type 2 diabetes mellitus	5.49e-06	8.39e-05	CbGpPWpGaD
Toremifene—CYP3A4—Metabolism—LIPC—type 2 diabetes mellitus	5.45e-06	8.34e-05	CbGpPWpGaD
Toremifene—CYP3A4—Metabolism—HBA1—type 2 diabetes mellitus	5.45e-06	8.34e-05	CbGpPWpGaD
Toremifene—CYP3A4—Metabolism—GCK—type 2 diabetes mellitus	5.45e-06	8.34e-05	CbGpPWpGaD
Toremifene—CYP3A4—Metabolism—CYP11A1—type 2 diabetes mellitus	5.42e-06	8.28e-05	CbGpPWpGaD
Toremifene—ABCB1—Metabolism—LPL—type 2 diabetes mellitus	5.4e-06	8.26e-05	CbGpPWpGaD
Toremifene—ESR1—Signaling Pathways—PIK3R1—type 2 diabetes mellitus	5.36e-06	8.19e-05	CbGpPWpGaD
Toremifene—ESR1—Signaling Pathways—NOS3—type 2 diabetes mellitus	5.36e-06	8.19e-05	CbGpPWpGaD
Toremifene—CYP3A4—Metabolism—SLC9A1—type 2 diabetes mellitus	5.32e-06	8.14e-05	CbGpPWpGaD
Toremifene—ABCB1—Metabolism—ADCY5—type 2 diabetes mellitus	5.29e-06	8.08e-05	CbGpPWpGaD
Toremifene—ABCB1—Metabolism—GPX1—type 2 diabetes mellitus	5.27e-06	8.05e-05	CbGpPWpGaD
Toremifene—CYP3A4—Metabolism—CETP—type 2 diabetes mellitus	5.26e-06	8.04e-05	CbGpPWpGaD
Toremifene—ABCB1—Metabolism—CD36—type 2 diabetes mellitus	5.13e-06	7.84e-05	CbGpPWpGaD
Toremifene—ABCB1—Metabolism—PPP2CA—type 2 diabetes mellitus	5.07e-06	7.75e-05	CbGpPWpGaD
Toremifene—ESR1—Signaling Pathways—RELA—type 2 diabetes mellitus	5.04e-06	7.71e-05	CbGpPWpGaD
Toremifene—CYP1A1—Metabolism—PPARG—type 2 diabetes mellitus	4.94e-06	7.55e-05	CbGpPWpGaD
Toremifene—CYP3A4—Metabolism—SREBF1—type 2 diabetes mellitus	4.89e-06	7.48e-05	CbGpPWpGaD
Toremifene—CYP3A4—Metabolism—SNAP25—type 2 diabetes mellitus	4.89e-06	7.48e-05	CbGpPWpGaD
Toremifene—CYP3A4—Metabolism—PSMD6—type 2 diabetes mellitus	4.89e-06	7.48e-05	CbGpPWpGaD
Toremifene—ABCB1—Metabolism—MTHFR—type 2 diabetes mellitus	4.86e-06	7.43e-05	CbGpPWpGaD
Toremifene—CYP1A1—Metabolism—INS—type 2 diabetes mellitus	4.84e-06	7.4e-05	CbGpPWpGaD
Toremifene—CYP3A4—Metabolism—CTGF—type 2 diabetes mellitus	4.8e-06	7.34e-05	CbGpPWpGaD
Toremifene—ABCB1—Metabolism—PPARA—type 2 diabetes mellitus	4.77e-06	7.29e-05	CbGpPWpGaD
Toremifene—CYP3A4—Metabolism—HMGCR—type 2 diabetes mellitus	4.76e-06	7.27e-05	CbGpPWpGaD
Toremifene—CYP1A2—Metabolism—GNB3—type 2 diabetes mellitus	4.73e-06	7.24e-05	CbGpPWpGaD
Toremifene—CYP1A2—Metabolism—PPARGC1A—type 2 diabetes mellitus	4.73e-06	7.24e-05	CbGpPWpGaD
Toremifene—CYP1A2—Metabolism—HMOX1—type 2 diabetes mellitus	4.71e-06	7.21e-05	CbGpPWpGaD
Toremifene—CYP3A4—Metabolism—ADRA2A—type 2 diabetes mellitus	4.65e-06	7.12e-05	CbGpPWpGaD
Toremifene—CYP1A2—Metabolism—CAT—type 2 diabetes mellitus	4.65e-06	7.11e-05	CbGpPWpGaD
Toremifene—ABCB1—Metabolism—AGT—type 2 diabetes mellitus	4.62e-06	7.06e-05	CbGpPWpGaD
Toremifene—ESR1—Signaling Pathways—CASP3—type 2 diabetes mellitus	4.55e-06	6.96e-05	CbGpPWpGaD
Toremifene—ABCB1—Metabolism—CALM1—type 2 diabetes mellitus	4.54e-06	6.94e-05	CbGpPWpGaD
Toremifene—ABCB1—Metabolism—APOE—type 2 diabetes mellitus	4.53e-06	6.92e-05	CbGpPWpGaD
Toremifene—CYP1A2—Metabolism—APOB—type 2 diabetes mellitus	4.51e-06	6.9e-05	CbGpPWpGaD
Toremifene—ABCB1—Metabolism—APOA1—type 2 diabetes mellitus	4.47e-06	6.84e-05	CbGpPWpGaD
Toremifene—CYP3A4—Metabolism—CYP2E1—type 2 diabetes mellitus	4.47e-06	6.84e-05	CbGpPWpGaD
Toremifene—CYP1A1—Metabolism—ALB—type 2 diabetes mellitus	4.44e-06	6.79e-05	CbGpPWpGaD
Toremifene—CYP3A4—Metabolism—CYP1A2—type 2 diabetes mellitus	4.42e-06	6.76e-05	CbGpPWpGaD
Toremifene—CYP3A4—Metabolism—SLC2A1—type 2 diabetes mellitus	4.42e-06	6.76e-05	CbGpPWpGaD
Toremifene—CYP1A2—Metabolism—GSTM1—type 2 diabetes mellitus	4.39e-06	6.71e-05	CbGpPWpGaD
Toremifene—CYP1A2—Metabolism—LPL—type 2 diabetes mellitus	4.31e-06	6.59e-05	CbGpPWpGaD
Toremifene—ESR1—Signaling Pathways—MMP9—type 2 diabetes mellitus	4.3e-06	6.57e-05	CbGpPWpGaD
Toremifene—ESR1—Signaling Pathways—NFKB1—type 2 diabetes mellitus	4.25e-06	6.5e-05	CbGpPWpGaD
Toremifene—CYP1A1—Metabolism—NOS3—type 2 diabetes mellitus	4.25e-06	6.49e-05	CbGpPWpGaD
Toremifene—CYP1A1—Metabolism—PIK3R1—type 2 diabetes mellitus	4.25e-06	6.49e-05	CbGpPWpGaD
Toremifene—CYP3A4—Metabolism—GCG—type 2 diabetes mellitus	4.24e-06	6.48e-05	CbGpPWpGaD
Toremifene—CYP3A4—Metabolism—SLC2A4—type 2 diabetes mellitus	4.24e-06	6.48e-05	CbGpPWpGaD
Toremifene—CYP1A2—Metabolism—ADCY5—type 2 diabetes mellitus	4.22e-06	6.45e-05	CbGpPWpGaD
Toremifene—CYP1A2—Metabolism—GPX1—type 2 diabetes mellitus	4.21e-06	6.43e-05	CbGpPWpGaD
Toremifene—CYP1A2—Metabolism—CD36—type 2 diabetes mellitus	4.1e-06	6.26e-05	CbGpPWpGaD
Toremifene—CYP1A2—Metabolism—PPP2CA—type 2 diabetes mellitus	4.04e-06	6.18e-05	CbGpPWpGaD
Toremifene—ESR1—Signaling Pathways—SRC—type 2 diabetes mellitus	3.96e-06	6.06e-05	CbGpPWpGaD
Toremifene—ABCB1—Metabolism—PPARG—type 2 diabetes mellitus	3.94e-06	6.03e-05	CbGpPWpGaD
Toremifene—CYP1A1—Metabolism—PTGS2—type 2 diabetes mellitus	3.88e-06	5.94e-05	CbGpPWpGaD
Toremifene—CYP1A2—Metabolism—MTHFR—type 2 diabetes mellitus	3.88e-06	5.93e-05	CbGpPWpGaD
Toremifene—ABCB1—Metabolism—INS—type 2 diabetes mellitus	3.87e-06	5.91e-05	CbGpPWpGaD
Toremifene—ESR1—Signaling Pathways—VEGFA—type 2 diabetes mellitus	3.86e-06	5.9e-05	CbGpPWpGaD
Toremifene—CYP1A2—Metabolism—PPARA—type 2 diabetes mellitus	3.81e-06	5.82e-05	CbGpPWpGaD
Toremifene—ESR1—Gene Expression—AKT1—type 2 diabetes mellitus	3.79e-06	5.79e-05	CbGpPWpGaD
Toremifene—CYP1A2—Metabolism—AGT—type 2 diabetes mellitus	3.69e-06	5.64e-05	CbGpPWpGaD
Toremifene—CYP3A4—Metabolism—GNB3—type 2 diabetes mellitus	3.65e-06	5.59e-05	CbGpPWpGaD
Toremifene—CYP3A4—Metabolism—PPARGC1A—type 2 diabetes mellitus	3.65e-06	5.59e-05	CbGpPWpGaD
Toremifene—CYP3A4—Metabolism—HMOX1—type 2 diabetes mellitus	3.64e-06	5.56e-05	CbGpPWpGaD
Toremifene—CYP1A2—Metabolism—CALM1—type 2 diabetes mellitus	3.63e-06	5.54e-05	CbGpPWpGaD
Toremifene—CYP1A2—Metabolism—APOE—type 2 diabetes mellitus	3.61e-06	5.52e-05	CbGpPWpGaD
Toremifene—CYP3A4—Metabolism—CAT—type 2 diabetes mellitus	3.59e-06	5.49e-05	CbGpPWpGaD
Toremifene—CYP1A2—Metabolism—APOA1—type 2 diabetes mellitus	3.57e-06	5.46e-05	CbGpPWpGaD
Toremifene—ABCB1—Metabolism—ALB—type 2 diabetes mellitus	3.54e-06	5.42e-05	CbGpPWpGaD
Toremifene—ESR1—Signaling Pathways—TGFB1—type 2 diabetes mellitus	3.54e-06	5.42e-05	CbGpPWpGaD
Toremifene—CYP3A4—Metabolism—APOB—type 2 diabetes mellitus	3.48e-06	5.33e-05	CbGpPWpGaD
Toremifene—ESR1—Signaling Pathways—EGFR—type 2 diabetes mellitus	3.47e-06	5.31e-05	CbGpPWpGaD
Toremifene—ABCB1—Metabolism—NOS3—type 2 diabetes mellitus	3.39e-06	5.18e-05	CbGpPWpGaD
Toremifene—ABCB1—Metabolism—PIK3R1—type 2 diabetes mellitus	3.39e-06	5.18e-05	CbGpPWpGaD
Toremifene—CYP3A4—Metabolism—GSTM1—type 2 diabetes mellitus	3.39e-06	5.18e-05	CbGpPWpGaD
Toremifene—CYP3A4—Metabolism—LPL—type 2 diabetes mellitus	3.33e-06	5.09e-05	CbGpPWpGaD
Toremifene—CYP3A4—Metabolism—ADCY5—type 2 diabetes mellitus	3.26e-06	4.98e-05	CbGpPWpGaD
Toremifene—CYP3A4—Metabolism—GPX1—type 2 diabetes mellitus	3.25e-06	4.96e-05	CbGpPWpGaD
Toremifene—CYP3A4—Metabolism—CD36—type 2 diabetes mellitus	3.16e-06	4.83e-05	CbGpPWpGaD
Toremifene—CYP1A2—Metabolism—PPARG—type 2 diabetes mellitus	3.15e-06	4.81e-05	CbGpPWpGaD
Toremifene—CYP3A4—Metabolism—PPP2CA—type 2 diabetes mellitus	3.12e-06	4.77e-05	CbGpPWpGaD
Toremifene—ABCB1—Metabolism—PTGS2—type 2 diabetes mellitus	3.1e-06	4.74e-05	CbGpPWpGaD
Toremifene—CYP1A2—Metabolism—INS—type 2 diabetes mellitus	3.09e-06	4.72e-05	CbGpPWpGaD
Toremifene—CYP3A4—Metabolism—MTHFR—type 2 diabetes mellitus	3e-06	4.58e-05	CbGpPWpGaD
Toremifene—CYP3A4—Metabolism—PPARA—type 2 diabetes mellitus	2.94e-06	4.49e-05	CbGpPWpGaD
Toremifene—CYP3A4—Metabolism—AGT—type 2 diabetes mellitus	2.85e-06	4.35e-05	CbGpPWpGaD
Toremifene—CYP1A2—Metabolism—ALB—type 2 diabetes mellitus	2.83e-06	4.33e-05	CbGpPWpGaD
Toremifene—CYP3A4—Metabolism—CALM1—type 2 diabetes mellitus	2.8e-06	4.28e-05	CbGpPWpGaD
Toremifene—CYP3A4—Metabolism—APOE—type 2 diabetes mellitus	2.79e-06	4.26e-05	CbGpPWpGaD
Toremifene—CYP3A4—Metabolism—APOA1—type 2 diabetes mellitus	2.76e-06	4.21e-05	CbGpPWpGaD
Toremifene—CYP1A2—Metabolism—PIK3R1—type 2 diabetes mellitus	2.71e-06	4.14e-05	CbGpPWpGaD
Toremifene—CYP1A2—Metabolism—NOS3—type 2 diabetes mellitus	2.71e-06	4.14e-05	CbGpPWpGaD
Toremifene—ESR1—Signaling Pathways—IL6—type 2 diabetes mellitus	2.67e-06	4.08e-05	CbGpPWpGaD
Toremifene—CYP1A2—Metabolism—PTGS2—type 2 diabetes mellitus	2.48e-06	3.79e-05	CbGpPWpGaD
Toremifene—ESR1—Signaling Pathways—AKT1—type 2 diabetes mellitus	2.46e-06	3.77e-05	CbGpPWpGaD
Toremifene—CYP3A4—Metabolism—PPARG—type 2 diabetes mellitus	2.43e-06	3.71e-05	CbGpPWpGaD
Toremifene—CYP3A4—Metabolism—INS—type 2 diabetes mellitus	2.38e-06	3.64e-05	CbGpPWpGaD
Toremifene—CYP3A4—Metabolism—ALB—type 2 diabetes mellitus	2.18e-06	3.34e-05	CbGpPWpGaD
Toremifene—CYP3A4—Metabolism—PIK3R1—type 2 diabetes mellitus	2.09e-06	3.19e-05	CbGpPWpGaD
Toremifene—CYP3A4—Metabolism—NOS3—type 2 diabetes mellitus	2.09e-06	3.19e-05	CbGpPWpGaD
Toremifene—CYP1A1—Metabolism—AKT1—type 2 diabetes mellitus	1.95e-06	2.98e-05	CbGpPWpGaD
Toremifene—CYP3A4—Metabolism—PTGS2—type 2 diabetes mellitus	1.91e-06	2.92e-05	CbGpPWpGaD
Toremifene—ABCB1—Metabolism—AKT1—type 2 diabetes mellitus	1.56e-06	2.38e-05	CbGpPWpGaD
Toremifene—CYP1A2—Metabolism—AKT1—type 2 diabetes mellitus	1.24e-06	1.9e-05	CbGpPWpGaD
Toremifene—CYP3A4—Metabolism—AKT1—type 2 diabetes mellitus	9.6e-07	1.47e-05	CbGpPWpGaD
